Santen Pharmaceutical Co., Ltd. (4536.T) - Quarterly Income Statement

Home
4536.T
Financials

1698 (JPY) • At close November 13, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q3	2016 Q2	2016 Q1	2015 Q4	2015 Q3	2015 Q2	2015 Q1	2014 Q4	2014 Q3	2014 Q2	2014 Q1	2013 Q4	2013 Q3	2013 Q2	2013 Q1	2012 Q4	2012 Q3	2012 Q2	2012 Q1	2011 Q4	2011 Q3	2011 Q2	2011 Q1	2010 Q4	2010 Q3	2010 Q2	2010 Q1	2009 Q4	2009 Q3	2009 Q2	2009 Q1	2008 Q4	2008 Q3	2008 Q2
Revenue Numbers are in millions	74,771	79,132	77,027	73,417	72,389	79,251	70,871	63,382	65,533	70,456	67,042	63,773	64,986	67,819	62,881	61,342	57,563	59,229	63,551	59,639	59,136	60,816	58,866	57,861	56,483	56,350	57,817	54,826	55,949	48,429	52,837	47,823	50,006	46,087	51,331	49,898	47,975	44,989	44,917	38,243	33,682	39,717	39,683	34,949	34,314	30,641	31,710	28,757	27,958	27,978	29,649	28,939	27,850	28,707	28,191	27,702	26,212	24,294	27,176	29,821	29,302	23,808	25,592	26,754
Cost of Revenue Numbers are in millions	34,438	34,044	32,145	29,431	30,024	27,501	29,548	27,496	28,406	26,967	29,837	25,943	26,924	22,324	26,192	24,964	24,741	20,474	26,056	24,182	24,120	20,950	24,042	22,750	23,022	20,228	23,179	21,390	21,581	17,333	20,797	18,441	18,395	16,098	20,229	18,633	17,869	14,903	14,877	13,009	13,584	15,533	15,411	13,659	13,501	11,746	10,934	9,373	9,448	8,435	9,183	9,115	8,652	8,246	8,754	8,895	8,540	8,049	8,892	9,182	8,585	8,863	8,660	9,281
Gross Profit Numbers are in millions	40,333	45,088	44,882	43,986	42,365	51,750	41,323	35,886	37,127	43,489	37,205	37,830	38,062	45,495	36,689	36,378	32,822	38,755	37,495	35,457	35,016	39,866	34,824	35,111	33,461	36,122	34,638	33,436	34,368	31,096	32,040	29,382	31,611	29,989	31,102	31,265	30,106	30,086	30,040	25,234	20,098	24,184	24,272	21,290	20,813	18,895	20,776	19,384	18,510	19,543	20,466	19,824	19,198	20,461	19,437	18,807	17,672	16,245	18,284	20,639	20,717	14,945	16,932	17,473
Gross Profit Ratio Numbers are in millions	0.539	0.57	0.583	0.599	0.585	0.653	0.583	0.566	0.567	0.617	0.555	0.593	0.586	0.671	0.583	0.593	0.57	0.654	0.59	0.595	0.592	0.656	0.592	0.607	0.592	0.641	0.599	0.61	0.614	0.642	0.606	0.614	0.632	0.651	0.606	0.627	0.628	0.669	0.669	0.66	0.597	0.609	0.612	0.609	0.607	0.617	0.655	0.674	0.662	0.699	0.69	0.685	0.689	0.713	0.689	0.679	0.674	0.669	0.673	0.692	0.707	0.628	0.662	0.653
Reseach & Development Expenses Numbers are in millions	5,504	7,208	5,747	6,159	6,301	6,615	7,415	7,168	7,099	7,574	6,464	6,218	6,121	6,459	6,530	5,507	5,616	6,188	5,741	5,238	6,174	6,668	6,128	5,345	5,619	6,503	6,154	6,129	5,613	6,856	5,626	5,146	5,158	5,706	5,040	4,657	4,587	17,477	4,296	4,099	4,071	19,040	0	0	0	16,719	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	0	26,780	21,575	22,108	21,066	30,755	23,206	22,868	19,427	24,176	20,671	19,205	20,447	26,733	19,579	17,691	15,551	20,525	19,413	17,375	16,047	20,049	17,749	17,301	16,173	19,284	17,828	16,620	15,056	17,610	15,845	14,638	14,100	16,339	15,480	14,274	13,313	-9,263	12,681	11,688	10,177	-5,387	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	0	21,481	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15,950	0	0	0	15,238	0	0	0	12,223	0	0	0	6,751	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	21,379	26,780	21,575	22,108	21,066	30,755	23,206	22,868	19,427	24,176	20,671	19,205	20,447	26,733	19,579	17,691	15,551	20,525	19,413	17,375	16,047	20,049	17,749	17,301	16,173	19,284	17,828	16,620	15,056	17,610	15,845	14,638	14,100	16,339	15,480	14,274	13,313	2,960	12,681	11,688	10,177	1,364	15,095	14,647	12,998	1,932	13,284	12,425	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Expenses Numbers are in millions	0	0	0	0	0	0	0	0	2,267	2,232	2,495	2,757	1,959	26,655	1,999	2,509	3,639	7,450	2,411	3,078	3,548	1,707	-1,885	1,656	1,654	1,732	1,608	1,704	1,642	1,639	1,869	1,621	1,542	2,185	1,546	-42,252	1,407	19,050	150	70	-10	-134	165	76	47	-99	-134	12	377	129	295	41	416	52	334	-15	461	-2	318	44	358	46	314	203
Operating Expenses Numbers are in millions	29,611	33,988	33,823	31,636	29,615	44,693	32,450	63,240	28,793	33,982	29,630	28,180	28,527	59,847	28,108	25,707	24,806	34,163	27,565	25,691	25,769	28,424	21,992	24,302	23,446	27,519	25,590	24,453	22,311	26,105	23,340	21,405	20,800	24,230	22,066	-23,321	19,307	19,050	18,896	17,432	14,706	20,404	15,095	14,647	12,998	14,787	13,284	12,425	12,387	15,031	12,816	13,016	11,435	11,829	11,441	11,331	11,034	12,315	11,611	11,910	10,408	10,949	11,071	11,732
Operating Income Numbers are in millions	13,156	11,100	11,058	12,350	12,750	7,057	8,874	-27,354	8,333	9,506	7,575	9,650	9,537	-14,351	8,581	10,670	8,016	4,593	9,931	9,766	9,246	11,441	12,832	10,809	10,016	8,604	9,048	8,983	12,056	4,991	8,700	7,976	10,811	5,759	9,036	54,586	10,799	11,037	11,143	7,803	5,391	3,781	9,176	6,643	7,814	4,109	7,492	6,958	6,122	4,513	7,650	6,808	7,762	8,631	7,994	7,474	6,637	3,931	6,672	8,728	10,308	3,997	5,861	5,740
Operating Income Ratio Numbers are in millions	0.176	0.14	0.144	0.168	0.176	0.089	0.125	-0.432	0.127	0.135	0.113	0.151	0.147	-0.212	0.136	0.174	0.139	0.078	0.156	0.164	0.156	0.188	0.218	0.187	0.177	0.153	0.156	0.164	0.215	0.103	0.165	0.167	0.216	0.125	0.176	1.094	0.225	0.245	0.248	0.204	0.16	0.095	0.231	0.19	0.228	0.134	0.236	0.242	0.219	0.161	0.258	0.235	0.279	0.301	0.284	0.27	0.253	0.162	0.246	0.293	0.352	0.168	0.229	0.215
Total Other Income Expenses Net Numbers are in millions	294	-1,424	-1,574	-1,143	118	-1,263	-1,365	-822	741	437	-295	-428	312	-194	28	-677	343	-1,466	691	-360	-244	-682	-218	-474	-561	1,118	-194	-379	153	42	1,062	-1,204	-558	-749	88	-477	427	-11	-582	-186	-387	-759	712	-876	402	206	308	-44	441	212	328	98	420	-121	186	-131	403	-253	-408	-530	161	-481	452	146
Income Before Tax Numbers are in millions	13,450	960	9,484	11,207	12,868	5,794	7,509	-28,176	9,074	9,943	7,280	9,222	9,552	-14,545	8,609	9,994	8,359	3,127	10,556	9,406	9,002	10,712	12,614	10,335	9,455	9,722	8,854	8,604	12,209	5,033	9,762	6,773	10,253	5,010	9,124	54,109	11,226	11,026	11,176	8,163	5,498	3,022	9,888	5,767	8,216	4,315	7,799	6,914	6,563	4,725	7,978	6,906	8,182	8,510	8,180	7,343	7,040	3,678	6,264	8,198	10,469	3,516	6,313	5,886
Income Before Tax Ratio Numbers are in millions	0.18	0.012	0.123	0.153	0.178	0.073	0.106	-0.445	0.138	0.141	0.109	0.145	0.147	-0.214	0.137	0.163	0.145	0.053	0.166	0.158	0.152	0.176	0.214	0.179	0.167	0.173	0.153	0.157	0.218	0.104	0.185	0.142	0.205	0.109	0.178	1.084	0.234	0.245	0.249	0.213	0.163	0.076	0.249	0.165	0.239	0.141	0.246	0.24	0.235	0.169	0.269	0.239	0.294	0.296	0.29	0.265	0.269	0.151	0.23	0.275	0.357	0.148	0.247	0.22
Income Tax Expense Numbers are in millions	2,843	-3,808	2,179	2,344	2,456	4,689	1,578	538	2,379	2,050	2,238	2,294	2,185	-244	1,362	2,420	2,235	1,691	3,406	2,667	2,612	2,137	3,624	2,810	2,604	1,808	-3,248	2,370	3,294	1,792	2,550	1,496	2,930	1,524	2,894	17,994	3,685	3,184	4,085	2,795	1,767	1,288	3,507	2,334	2,654	1,930	2,642	2,212	2,286	2,331	3,117	2,526	2,656	1,855	2,775	2,648	2,462	1,195	1,694	3,076	3,921	1,100	2,329	2,299
Net Income Numbers are in millions	10,633	29	7,332	8,866	10,414	1,116	5,977	-28,714	6,663	7,922	5,042	6,928	7,342	-14,116	7,129	7,575	6,189	3,340	7,149	6,739	6,399	8,576	8,991	7,525	6,852	7,913	12,102	6,233	9,012	3,242	7,212	5,182	7,323	3,486	6,230	36,116	7,541	7,842	7,504	5,694	4,065	1,733	6,382	3,432	5,562	2,384	5,158	4,701	4,277	2,394	4,861	4,379	5,526	6,656	5,405	4,694	4,578	2,483	4,569	5,122	6,548	2,416	3,983	3,587
Net Income Ratio Numbers are in millions	0.142	0	0.095	0.121	0.144	0.014	0.084	-0.453	0.102	0.112	0.075	0.109	0.113	-0.208	0.113	0.123	0.108	0.056	0.112	0.113	0.108	0.141	0.153	0.13	0.121	0.14	0.209	0.114	0.161	0.067	0.136	0.108	0.146	0.076	0.121	0.724	0.157	0.174	0.167	0.149	0.121	0.044	0.161	0.098	0.162	0.078	0.163	0.163	0.153	0.086	0.164	0.151	0.198	0.232	0.192	0.169	0.175	0.102	0.168	0.172	0.223	0.101	0.156	0.134
EPS Numbers are in millions	29.61	0.083	20.73	24.6	27.93	2.96	15.49	-75.59	16.79	19.81	12.6	17.43	18.46	-35.34	17.98	19.09	15.49	8.37	17.92	16.91	16.03	21.07	22.1	18.49	16.85	19.47	29.71	15.36	22.2	7.96	17.71	12.52	17.68	8.42	15.05	87.28	18.24	18.97	18.17	13.79	9.84	4.2	15.46	8.32	13.48	5.78	12.5	10.79	9.81	5.49	11.15	10.05	12.69	15.29	12.7	11.03	10.76	5.84	10.74	12.05	15.4	5.68	9.18	8.27
EPS Diluted Numbers are in millions	29.5	0.083	20.66	24.52	27.85	2.96	15.46	-75.59	16.77	19.78	12.59	17.39	18.44	-35.34	17.94	19.04	15.46	8.37	17.86	16.86	15.99	21.07	22.03	18.44	16.79	19.47	29.6	15.3	22.12	7.96	17.64	12.48	17.61	8.42	14.99	86.9	18.15	18.97	18.08	13.73	9.81	4.2	15.46	8.32	13.44	5.78	12.5	10.79	9.81	5.49	11.15	10.05	12.67	15.29	12.7	11.03	10.74	5.84	10.74	12.05	15.4	5.68	9.18	8.27
EBITDA Numbers are in millions	18,565	7,201	16,230	17,404	17,831	11,320	13,426	-23,217	14,188	15,350	12,356	14,220	12,970	-9,648	13,082	14,758	12,662	8,897	14,072	13,923	13,810	14,226	15,861	13,617	13,264	12,525	12,068	11,747	15,174	7,593	12,253	10,436	13,634	8,244	11,709	56,948	13,435	12,752	13,545	10,322	6,503	4,988	10,815	7,576	9,041	5,217	8,628	7,710	7,332	5,604	8,707	7,600	8,851	9,415	8,929	8,103	7,791	4,920	7,134	9,071	11,329	4,490	7,320	5,908
EBITDA Ratio Numbers are in millions	0.248	0.198	0.193	0.226	0.236	0.135	0.18	-0.366	0.209	0.212	0.176	0.218	0.21	-0.145	0.208	0.241	0.22	0.15	0.221	0.233	0.233	0.234	0.269	0.235	0.235	0.206	0.209	0.214	0.271	0.157	0.232	0.218	0.273	0.179	0.228	1.141	0.28	0.283	0.302	0.27	0.193	0.126	0.261	0.217	0.265	0.171	0.272	0.268	0.262	0.201	0.294	0.261	0.318	0.328	0.322	0.293	0.301	0.203	0.27	0.311	0.387	0.192	0.287	0.221

Santen Pharmaceutical Co., Ltd.

TSE:4536.T Add to watchlist

TSE:4536.T